Edwin Verlind
Impact in
-
- Genetic factors in colorectal cancer
-
- Cancer Genomics and Diagnostics
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Genetics 4
- Genomic variations and chromosomal abnormalities 3
- Co-authors
- Charles H.C.M. Buys (19 shared papers)Robert M.W. Hofstra (10 shared papers)Hans Scheffer (15 shared papers)Rob G.J. Mensink (2 shared papers)Harry Hollema (2 shared papers)Ate G.J. van der Zee (2 shared papers)Maran J.W. Berends (2 shared papers)Jan H. Kleibeuker (2 shared papers)
- Journals
- Human Genetics (5 papers)Human Mutation (3 papers)European Journal of Human Genetics (2 papers)Genes Chromosomes and Cancer (2 papers)Gastroenterology (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Edwin Verlind
28 papers receiving 662 citations
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 253
- Cancer Research 101
- Oncology 181
- Genetics 56
- Rheumatology 73
Countries citing papers authored by Edwin Verlind
This map shows the geographic impact of Edwin Verlind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Verlind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Verlind more than expected).
Fields of papers citing papers by Edwin Verlind
This network shows the impact of papers produced by Edwin Verlind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Verlind. The network helps show where Edwin Verlind may publish in the future.
Co-authors
The 25 scholars most cited alongside Edwin Verlind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 128 | |
| 2 | 2001 | 126 | |
| 3 | 2000 | 59 | |
| 4 | 1998 | 51 | |
| 5 | 1999 | 41 | |
| 6 | 2000 | 32 | |
| 7 | 2000 | 26 | |
| 8 | 1999 | 25 | |
| 9 | 2003 | 21 | |
| 10 | 2002 | 20 | |
| 11 | 2001 | 20 | |
| 12 | 1995 | 19 | |
| 13 | 2000 | 17 | |
| 14 | 2002 | 16 | |
| 15 | 1989 | 15 | |
| 16 | 1997 | 14 | |
| 17 | 2000 | 10 | |
| 18 | 1999 | 10 | |
| 19 | 1994 | 7 | |
| 20 | 1993 | 7 |
About Edwin Verlind
Edwin Verlind is a scholar working on Molecular Biology, Genetics, Cellular and Molecular Neuroscience, Oncology and Cell Biology, having authored 28 papers that have together received 690 indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (3 papers), Cystic Fibrosis Research Advances (3 papers), Glycogen Storage Diseases and Myoclonus (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Amino Acid Enzymes and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers) and Axon Guidance and Neuronal Signaling (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (253 citations), Cancer Research (101 citations), Oncology (181 citations), Genetics (56 citations) and Rheumatology (73 citations). Edwin Verlind has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Charles H.C.M. Buys, Robert M.W. Hofstra, Hans Scheffer, Rob G.J. Mensink, Harry Hollema, Ate G.J. van der Zee, Maran J.W. Berends, Jan H. Kleibeuker, Ying Wu and Tineke van der Sluis. Their work appears in journals such as Human Genetics, Human Mutation, European Journal of Human Genetics, Genes Chromosomes and Cancer and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.